Cause-specific Death in Adults with Type 1 Diabetes and Type 2 Diabetes: Insights from the UK Biobank

Overview

Journal Diabetes Obes Metab

Specialty Endocrinology

Date 2024 Oct 15

PMID 39402726

Authors

John W Ostrominski

So Mi Jemma Cho

Muthiah Vaduganathan

Michael C Honigberg

Affiliations

Soon will be listed here.

References

van Raalte D, Bjornstad P, Persson F, Powell D, Castro R, Wang P . The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes. Diabetes Care. 2019; 42(10):1921-1929. PMC: 6905482. DOI: 10.2337/dc19-0937. View

Yang K, Yang X, Jin C, Ding S, Liu T, Ma B . Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019: population based study. BMJ. 2024; 385:e078432. PMC: 11167563. DOI: 10.1136/bmj-2023-078432. View

Navaneethan S, Zoungas S, Caramori M, Chan J, Heerspink H, Hurst C . Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update. Ann Intern Med. 2023; 176(3):381-387. DOI: 10.7326/M22-2904. View

Ludvigsson J . Immune Interventions at Onset of Type 1 Diabetes - Finally, a Bit of Hope. N Engl J Med. 2023; 389(23):2199-2201. DOI: 10.1056/NEJMe2312091. View

Forlenza G, McVean J, Beck R, Bauza C, Bailey R, Buckingham B . Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2023; 329(12):990-999. PMC: 9960020. DOI: 10.1001/jama.2023.2064. View

. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 385(9963):117-71. PMC: 4340604. DOI: 10.1016/S0140-6736(14)61682-2. View

Dandona P, Chaudhuri A, Ghanim H . Semaglutide in Early Type 1 Diabetes. N Engl J Med. 2023; 389(10):958-959. DOI: 10.1056/NEJMc2302677. View

Ostrominski J, Cho S, Vaduganathan M, Honigberg M . Cardiorenal Outcomes in Middle-Aged and Older Adults With Type 1 and Type 2 Diabetes. J Am Coll Cardiol. 2024; 84(14):1363-1366. PMC: 11424244. DOI: 10.1016/j.jacc.2024.06.024. View

Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M . Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects. Diabetes Care. 2007; 31(4):714-9. DOI: 10.2337/dc07-2124. View

10.

. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024. Diabetes Care. 2023; 47(Suppl 1):S179-S218. PMC: 10725811. DOI: 10.2337/dc24-S010. View

11.

Wright A, Kontopantelis E, Emsley R, Buchan I, Sattar N, Rutter M . Life Expectancy and Cause-Specific Mortality in Type 2 Diabetes: A Population-Based Cohort Study Quantifying Relationships in Ethnic Subgroups. Diabetes Care. 2016; 40(3):338-345. DOI: 10.2337/dc16-1616. View

12.

Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N . Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011; 364(9):829-841. PMC: 4109980. DOI: 10.1056/NEJMoa1008862. View

13.

von Herrath M, Bain S, Bode B, Clausen J, Coppieters K, Gaysina L . Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinol. 2021; 9(4):212-224. DOI: 10.1016/S2213-8587(21)00019-X. View

14.

Hughes M, Addala A, Buckingham B . Digital Technology for Diabetes. N Engl J Med. 2023; 389(22):2076-2086. DOI: 10.1056/NEJMra2215899. View

15.

Secrest A, Becker D, Kelsey S, LaPorte R, Orchard T . Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes. 2010; 59(12):3216-22. PMC: 2992785. DOI: 10.2337/db10-0862. View

16.

. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023; 402(10397):203-234. PMC: 10364581. DOI: 10.1016/S0140-6736(23)01301-6. View

17.

Thomas N, McGovern A, Young K, Sharp S, Weedon M, Hattersley A . Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches. J Clin Epidemiol. 2022; 153:34-44. DOI: 10.1016/j.jclinepi.2022.10.022. View

18.

Fry A, Littlejohns T, Sudlow C, Doherty N, Adamska L, Sprosen T . Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am J Epidemiol. 2017; 186(9):1026-1034. PMC: 5860371. DOI: 10.1093/aje/kwx246. View

19.

Groop P, Dandona P, Phillip M, Gillard P, Edelman S, Jendle J . Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials. Lancet Diabetes Endocrinol. 2020; 8(10):845-854. DOI: 10.1016/S2213-8587(20)30280-1. View

20.

Kristofi R, Bodegard J, Norhammar A, Thuresson M, Nathanson D, Nystrom T . Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study. Diabetes Care. 2021; 44(5):1211-1218. PMC: 8132335. DOI: 10.2337/dc20-2839. View